The official blog of the Lung Institute.

Top 5 Things People Don’t Know about Stem Cell Treatments for Lung Disease

19 Nov 2013
| Under Press | Posted by | 0 Comments
Top 5 Things People Don't Know about Stem Cell Treatments for Lung Disease

Lung Institute Supports COPD Awareness Month by Educating Public on Innovative Pulmonary Treatment Options

Tampa, Fla. (November 19, 2013) – In support of chronic obstructive pulmonary disease (COPD) Awareness Month and the US COPD Coalition, the Lung Institute is informing people about innovative treatment options for lung disease. Once considered an alternative form of treatment for lung disease, stem cell treatments have taken center stage as a viable option for people with chronic pulmonary diseases. To dispel any controversy or misunderstanding about the subject of stem cell treatments, the Lung Institute offers the following five true and false facts for people to learn more about stem cell treatments.

Top 5 Things People Don’t Know about Stem Cell Treatments for Lung Disease

  • T or F: Individuals with COPD don’t have many treatment options. FALSE. Although COPD is a progressive disorder, people have many types of treatment options, including the promising option of stem cell therapy.
  • T or F: Stem cell procedures are always invasive and painful.  FALSE. Many types of stem cell procedures, like the bone marrow treatment and the venous treatment performed at the Lung Institute are minimally invasive.
  • T or F: All stem cell treatments are unethical because they utilize fetal or embryonic stem cells. FALSE. Many stem cell procedures use autologous stem cells, which are derived from a person’s own blood or bone marrow.
  • T or F: Stem cell treatments have been known to improve quality of life for people with many types of chronic lung diseases. TRUE. Stem cell treatments have been known to improve the quality of life of patients suffering from many types of chronic lung diseases.
  • T or F: There is a risk of rejection by the body with autologous stem cell therapy. FALSE. Since the stem cells are derived from the patient’s own body, there is no risk of rejection.

About Lung Institute

The Lung Institute is a leading medical provider of regenerative cellular therapy for lung diseases such as COPD, pulmonary fibrosis and interstitial lung disease. Founded in 2013 in Tampa, Fla., the Lung Institute currently has clinics in Tampa, Fla., Nashville, Tenn., Scottsdale, Ariz., Pittsburgh, Pa. and Dallas, Texas. For more information, please visit www.lunginstitute.com or call (800) 729-3065.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.